Cargando…

Serum Cystatin C Concentrations in Patients with Graves’ Ophthalmopathy

PURPOSE: To evaluate the concentration of serum cystatin C (CysC) in patients with Graves’ ophthalmopathy (GO) and the usability of the serum CysC concentrations in the follow-up of the disease. METHODS: Thirty patients with GO and 30 healthy age-matched volunteers were included in this cross-sectio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Can, Nagehan, Ozsoy, Ercan, Kobat, Sabiha Gungor, Yusufoglu, Elif, Ilhan, Nevin, Demir, Tamer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Ophthalmological Society 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597615/ https://www.ncbi.nlm.nih.gov/pubmed/33099562 http://dx.doi.org/10.3341/kjo.2020.0006

Ejemplares similares

Pediatric Canaliculitis: A Case Report
por: Eraslan Yusufoğlu, Elif, et al.
Publicado: (2019)

A rare cause of pediatric oculomotor nerve palsy: neurobrucellosis
por: Yusufoğlu, Elif, et al.
Publicado: (2022)

Evaluation of Central Macula, Retinal Nerve Fiber Layer, and Ganglion Cell Complex Thickness in Congenital Color Vision Deficiency
por: Ozsoy, Ercan, et al.
Publicado: (2020)

Adiponectin concentration in the orbital fat of patients with Graves’ ophthalmopathy
por: Soiberman, Uri, et al.
Publicado: (2013)

Autophagy in graves’ ophthalmopathy
por: Chen, Yu-Qing, et al.
Publicado: (2023)

Increased serum VEGF and b-FGF in Graves’ ophthalmopathy
por: Ye, Xiaozhen, et al.
Publicado: (2014)

Immunological Aspects of Graves' Ophthalmopathy
por: Łacheta, Dominika, et al.
Publicado: (2019)

The Influence of Juvenile Graves' Ophthalmopathy on Graves' Disease Course
por: Jankauskiene, Jurate, et al.
Publicado: (2017)

Graves' Ophthalmopathy: A Review of Immunogenetics
por: Khalilzadeh, Omid, et al.
Publicado: (2011)

Update on the medical treatment of Graves’ ophthalmopathy
por: Griepentrog, Gregory J, et al.
Publicado: (2009)

Radiotherapy in the treatment of Graves ophthalmopathy—to do it or not?
por: Zygulska, Aneta
Publicado: (2009)

Graves’ Ophthalmopathy Misdiagnosed as Relapsing Conjunctivitis
por: Chatziralli, Irini P., et al.
Publicado: (2010)

Imaging Evaluation of the Orbit in Graves Ophthalmopathy
por: SAS, T.N., et al.
Publicado: (2015)

Precision Medicine in Graves’ Disease and Ophthalmopathy
por: Elia, Giusy, et al.
Publicado: (2021)

Graves’ Ophthalmopathy in the Setting of Primary Hypothyroidism
por: Alajmi, Sarah, et al.
Publicado: (2022)

Orbital endoscopic decompression in Graves Ophthalmopathy
por: Lima, Wilma Terezinha Anselmo, et al.
Publicado: (2015)

Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model
por: Can, Nagehan, et al.
Publicado: (2015)

Simultaneous induction of Graves’ hyperthyroidism and Graves’ ophthalmopathy by TSHR genetic immunization in BALB/c mice
por: Xia, Nan, et al.
Publicado: (2017)

The Increment of Choroidal Thickness in Euthyroid Graves' Ophthalmopathy: Is It an Early Sign of Venous Congestion?
por: Cagiltay, Eylem, et al.
Publicado: (2018)

Predictive Factors of Development of Graves' Ophthalmopathy for Patients with Juvenile Graves' Disease
por: Jarusaitiene, Dalia, et al.
Publicado: (2016)

Comparative Evaluation of Oculometric Variables in Graves’ Ophthalmopathy
por: Miot, Hélio Amante, et al.
Publicado: (2009)

Severe Grave's Ophthalmopathy–missed for many years
por: Wani, Mohd Maqbool, et al.
Publicado: (2010)

Thyroid antibody-negative euthyroid Graves’ ophthalmopathy
por: Tabasum, Arshiya, et al.
Publicado: (2016)

The association of carotid cavernous fistula with Graves’ ophthalmopathy
por: Celik, Ozlem, et al.
Publicado: (2013)

The Influence of Prior Hyperthyroidism on Euthyroid Graves' Ophthalmopathy
por: Termote, Karolien, et al.
Publicado: (2014)

The Potential Role of Osteopontin in the Pathogenesis of Graves’ Ophthalmopathy
por: Lou, Heng, et al.
Publicado: (2021)

Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy
por: Fallahi, Poupak, et al.
Publicado: (2021)

Tear-derived exosomal biomarkers of Graves’ ophthalmopathy
por: Shi, Ting-Ting, et al.
Publicado: (2022)

Current insights of applying MRI in Graves’ ophthalmopathy
por: Song, Cheng, et al.
Publicado: (2022)

Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism
por: Le Moli, Rosario, et al.
Publicado: (2020)

Association of variant on the promoter of cluster of differentiation 74 in graves disease and graves ophthalmopathy
por: Liu, Yu-Huei, et al.
Publicado: (2020)

The Evolving Role of Selenium in the Treatment of Graves' Disease and Ophthalmopathy
por: Duntas, Leonidas H.
Publicado: (2012)

The relationship between Graves’ ophthalmopathy and dry eye syndrome
por: Selter, Jessica H, et al.
Publicado: (2014)

Corticosteroids for Graves' Ophthalmopathy: Systematic Review and Meta-Analysis
por: Tu, Xiaofang, et al.
Publicado: (2018)

Intravenous Glucocorticoid Treatment for Korean Graves' Ophthalmopathy Patients
por: Ahn, Hwa Young, et al.
Publicado: (2020)

Evaluation of the Effect of Proptosis on Choroidal Thickness in Graves’ Ophthalmopathy
por: Yıldırım, Gamze, et al.
Publicado: (2020)

Proptosis is associated with thiol-disulfide in patients with Graves’ ophthalmopathy
por: Acibucu, Fettah, et al.
Publicado: (2022)

ODP533 Graves’ Ophthalmopathy in the Setting of Primary Hypothyroidism
por: Alajmi, Sarah, et al.
Publicado: (2022)

THU668 Euthyroid Graves’ Ophthalmopathy: Case Series
por: Saleh Alfadl, Sultan, et al.
Publicado: (2023)

Symptoms and signs of dry eye in children with Graves‘ ophthalmopathy
por: Jankauskiene, Jurate, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pmepb421t7tbms40dgcl0gpmgl